Cell death: 1+1‰2

Nature Reviews Cancer

Volumn 12, Issue 7, 2012, Pages 449-

  McCarthy, Nicola ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; LAPATINIB;

APOPTOSIS; AUTOPHAGY; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CELL DEATH; CELL DIFFERENTIATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG TARGETING; ENZYME INHIBITION; EXPERIMENTAL NEOPLASM; GENE EXPRESSION; GENETIC ASSOCIATION; IN VITRO STUDY; INFLAMMATION; INHIBITION KINETICS; MONOTHERAPY; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUMOR XENOGRAFT;

EID: 84862758996     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3301     Document Type: Note

References (1)

1. Lee, M. J. et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signalling networks. Cell 149, 780-794 (2012)